AU2003282709A1 - Gene expression profiling of bladder cancer - Google Patents

Gene expression profiling of bladder cancer

Info

Publication number
AU2003282709A1
AU2003282709A1 AU2003282709A AU2003282709A AU2003282709A1 AU 2003282709 A1 AU2003282709 A1 AU 2003282709A1 AU 2003282709 A AU2003282709 A AU 2003282709A AU 2003282709 A AU2003282709 A AU 2003282709A AU 2003282709 A1 AU2003282709 A1 AU 2003282709A1
Authority
AU
Australia
Prior art keywords
gene expression
bladder cancer
expression profiling
profiling
bladder
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2003282709A
Other versions
AU2003282709A8 (en
Inventor
Geoffrey Childs
Carlos Cordon-Cardo
Marta Sanchez-Carbayo
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Memorial Sloan Kettering Cancer Center
Original Assignee
Sloan Kettering Institute for Cancer Research
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sloan Kettering Institute for Cancer Research filed Critical Sloan Kettering Institute for Cancer Research
Publication of AU2003282709A8 publication Critical patent/AU2003282709A8/en
Publication of AU2003282709A1 publication Critical patent/AU2003282709A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
    • C12Q1/6886—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material for cancer
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/112—Disease subtyping, staging or classification
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/118—Prognosis of disease development

Landscapes

  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Pathology (AREA)
  • Analytical Chemistry (AREA)
  • Zoology (AREA)
  • Genetics & Genomics (AREA)
  • Wood Science & Technology (AREA)
  • Physics & Mathematics (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • Molecular Biology (AREA)
  • Hospice & Palliative Care (AREA)
  • Biophysics (AREA)
  • Oncology (AREA)
  • Biochemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
AU2003282709A 2002-10-04 2003-10-03 Gene expression profiling of bladder cancer Abandoned AU2003282709A1 (en)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US41600202P 2002-10-04 2002-10-04
US41600302P 2002-10-04 2002-10-04
US60/416,002 2002-10-04
US60/416,003 2002-10-04
PCT/US2003/031620 WO2004033641A2 (en) 2002-10-04 2003-10-03 Gene expression profiling of bladder cancer

Publications (2)

Publication Number Publication Date
AU2003282709A8 AU2003282709A8 (en) 2004-05-04
AU2003282709A1 true AU2003282709A1 (en) 2004-05-04

Family

ID=32096131

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2003282709A Abandoned AU2003282709A1 (en) 2002-10-04 2003-10-03 Gene expression profiling of bladder cancer

Country Status (2)

Country Link
AU (1) AU2003282709A1 (en)
WO (1) WO2004033641A2 (en)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE102006007249B4 (en) * 2006-02-15 2008-07-31 Universitätsklinikum Schleswig-Holstein Method for the determination of bladder carcinomas of differentiation grade G2
WO2011016031A2 (en) 2009-08-03 2011-02-10 Yeda Research And Development Co. Ltd. Urinary biomarkers for cancer diagnosis
WO2023215278A1 (en) * 2022-05-03 2023-11-09 The Broad Institute, Inc. Modified immune cells and methods for use thereof

Also Published As

Publication number Publication date
AU2003282709A8 (en) 2004-05-04
WO2004033641A3 (en) 2006-08-24
WO2004033641A2 (en) 2004-04-22

Similar Documents

Publication Publication Date Title
AU2003253860A1 (en) Expression profile of lung cancer
AUPS054702A0 (en) Cancer therapy
AU2002259196A1 (en) Gene expression profiling
AU2003201741A1 (en) Cancer profiles
EP1572902A3 (en) HIGH POTENCY siRNAS FOR REDUCING THE EXPRESSION OF TARGET GENES
AU2003294205A1 (en) Prostate cancer biomarkers
AU2003224598A1 (en) Differentially-regulated prostate cancer genes
AU2003277910A1 (en) Ocular gene therapy
EP2561887B8 (en) Cancer therapy sensitizer
AU2003222197A1 (en) Inhibition of rna function
EP1594433A3 (en) Cancer therapy sensitizer
AU2003258662A1 (en) Use of 4-amino-quinazolines as anti cancer agents
AU2002360345A1 (en) Prostate cancer genes
AU2003279101A1 (en) Methylation profile of cancer
AU2002307154A1 (en) Prostate cancer expression profiles
AU2003223538A1 (en) Methods for the treatment of cancer
AU2003268923A1 (en) Treatment of aml
AU2003212826A1 (en) Cancer genes
AU2003282709A1 (en) Gene expression profiling of bladder cancer
AU2003283339A1 (en) Cancer therapy determination
AU2003231803A1 (en) Treatment of cancer with mefloquire
AU2003256931A1 (en) USES OF CIRCADIAN GENE mPER2
AU2002338431A1 (en) Sequence characteristics of bladder cancer
AU2003282564A1 (en) Gene profiling of single or multiple cells
AU2003296242A1 (en) Thia-epothilone derivatives for the treatment of cancer

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase